Intelivation Technologies received FDA 510(k) clearance to market the Hammerdesis Interphalangeal Fusion System.
Hammerdesis allows surgeons to correct hammertoe deformities and degenerative issues by affixing a distinctively designed implant on the patient’s toe joint, with the potential for significant intraoperative time and cost savings in the ambulatory surgery setting.
President of Intelivation, Amit Sinha, said, “This is a truly disruptive technology in a crowded area. Our product development and sales teams are looking forward to being a part of this market transformation that will make a major impact for surgeons and their patients for many years to come. We are currently preparing for our launch and post-market clinical data points to share with the orthopedic and podiatric communities.”
Intelivation Technologies received FDA 510(k) clearance to market the Hammerdesis Interphalangeal Fusion System.
Hammerdesis allows surgeons to correct hammertoe deformities and degenerative issues by affixing a distinctively designed implant on the patient’s toe joint, with the potential for significant intraoperative time and cost savings in...
Intelivation Technologies received FDA 510(k) clearance to market the Hammerdesis Interphalangeal Fusion System.
Hammerdesis allows surgeons to correct hammertoe deformities and degenerative issues by affixing a distinctively designed implant on the patient’s toe joint, with the potential for significant intraoperative time and cost savings in the ambulatory surgery setting.
President of Intelivation, Amit Sinha, said, “This is a truly disruptive technology in a crowded area. Our product development and sales teams are looking forward to being a part of this market transformation that will make a major impact for surgeons and their patients for many years to come. We are currently preparing for our launch and post-market clinical data points to share with the orthopedic and podiatric communities.”
Copy to clipboard 
